Jeffrey Lipman (Dagan Lonsdale, Dagan O Lonsdale)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Antimicrobial Resistance

Coronavirus Disease

Top Venues

Antibiotics (Basel, Switzerland)

British journal of clinical pharmacology

Journal of the Intensive Care Society

Current infectious disease reports

This page only lists publications with an associated author ORCID identifier.

Publications

Reya V Shah, Karin Kipper, Emma H Baker, Charlotte I S Barker, Isobel Oldfield, Barbara J Philips, Atholl Johnston, Jeffrey Lipman, Andrew Rhodes, Marina Basarab, Mike Sharland, Sarraa Almahdi, Rachel M Wake, Joseph F Standing, Jeffrey Lipman
Population Pharmacokinetic Study of Benzylpenicillin in Critically Unwell Adults. Antibiotics (Basel, Switzerland) 12 (4) (2023)
Reya V Shah, Karin Kipper, Emma H Baker, Charlotte I S Barker, Isobel Oldfield, Barbara J Philips, Atholl Johnston, Jeffrey Lipman, Andrew Rhodes, Marina Basarab, Mike Sharland, Sarraa Almahdi, Rachel M Wake, Joseph F Standing, Jeffrey Lipman
Population Pharmacokinetic Study of Benzylpenicillin in Critically Unwell Adults. Antibiotics (Basel, Switzerland) 12 (4) (2023)
Charlotte I S Barker, Karin Kipper, Jeffrey Lipman, Kirstie Wright, Georgina Thompson, Min Kim, Mark A Turner, Atholl Johnston, Michael Sharland, Joseph F Standing, null null
The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence. The Journal of antimicrobial chemotherapy (2023)
Akosua A Agyeman, Tao You, Phylinda L S Chan, Jeffrey Lipman, Christoforos Hadjichrysanthou, Tabitha Mahungu, Emmanuel Q Wey, David M Lowe, Marc C I Lipman, Judy Breuer, Frank Kloprogge, Joseph F Standing
Comparative assessment of viral dynamic models for SARS-CoV-2 for pharmacodynamic assessment in early treatment trials. British journal of clinical pharmacology 88 (12) (2022)
Alexander J Robbins, Nur Amalina Che Bakri, Edward Toke-Bjolgerud, Aaron Edwards, Asha Vikraman, Cathy Michalsky, Michael Fossler, Nana-Marie Lemm, Savviz Medhipour, William Budd, Athanasia Gravani, Lisa Hurley, Vikas Kapil, Aimee Jackson, Jeffrey Lipman, Victoria Latham, Michael Laffan, Neil Chapman, Nichola Cooper, Richard Szydlo, Joseph Boyle, Katrina M Pollock, David Owen
The effect of TRV027 on coagulation in COVID 19: A pilot randomized, placebo-controlled controlled trial. British journal of clinical pharmacology (2022)
Jeffrey Lipman, Liting Tong, Helen Farrah, Sarah Farnell-Ward, Chris Ryan, Ximena Watson, Maurizio Cecconi, Hans Flaatten, Jesper Fjølner, Christian Jung, Bertrand Guidet, Dylan de Lange, Wojciech Szczeklik, Johanna M Muessig, Susannah K Leaver
The clinical frailty scale - does it predict outcome of the very-old in UK ICUs? Journal of the Intensive Care Society 24 (2) (2022)
Chris F Duncan, Taryn Youngstein, Marianne D Kirrane, Jeffrey Lipman
Diagnostic Challenges in Sepsis. Current infectious disease reports 23 (12) (2021)
Despoina Koulenti, Kostoula Arvaniti, Mathew Judd, Natasha Lalos, Iona Tjoeng, Elena Xu, Apostolos Armaganidis, Jeffrey Lipman
Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat? Antibiotics (Basel, Switzerland) 9 (2) (2020)
Dagan O Lonsdale, Jeffrey Lipman
Antimicrobial Resistance: We Must Pursue a Collaborative, Global Approach and Use a "One Health" Approach. Antibiotics (Basel, Switzerland) 8 (4) (2019)
Jeffrey Lipman, Emma H Baker, Karin Kipper, Charlotte I S Barker, Barbara Philips, Andrew Rhodes, Mike Sharland, Joseph F Standing
Scaling beta-lactam antimicrobial pharmacokinetics from early life to old age. British journal of clinical pharmacology 85 (2) (2018)
Selma Audi, Daniel R Burrage, Jeffrey Lipman, Sarah Pontefract, Jamie J Coleman, Andrew W Hitchings, Emma H Baker
The 'top 100' drugs and classes in England: an updated 'starter formulary' for trainee prescribers. British journal of clinical pharmacology 84 (11) (2018)